Weekly Recap

Each week on Saturday morning, the NeurologyLive News Network puts together a weekly recap that offers a quick look into some of the top headlines in neurology news that you may have missed.

YTX-7739 Trials Suspended, ENSURE-2 Study of IMU-838 Initiated, Behavioral Involvement of FTD in ALS

January 22, 2022

Neurology News Network for the week ending January 22, 2022. [WATCH TIME: 4 minutes]

MAO-B Inhibitors Underused in PD, CMS Proposes Decision on Aducanumab Coverage, PREMIUM II Trial of gammaCore Published

January 15, 2022

Neurology News Network for the week ending January 15, 2022. [WATCH TIME: 4 minutes]

Awake vs Asleep DBS Impact, Worsened MS Following DMT Discontinuation, Anticoagulation Noninferior to Avoiding it

January 08, 2022

Neurology News Network for the week ending January 8, 2022. [WATCH TIME: 3 minutes]

Neurology News Network: Top FDA Approvals of 2021

January 01, 2022

Neurology News Network for the week ending January 1, 2022. [WATCH TIME: 4 minutes]

Aducanumab Cost Cut, REFINE-ALS Details Announced, NMOSD Shows Brighter Spotty Lesions Than MOGAD

December 25, 2021

Neurology News Network for the week ending December 25, 2021.

BXCL501 Study in Alzheimer Begins, Ublituximab BLA Accepted, Sublingual Apomorphine Shows Dominance

December 18, 2021

Neurology News Network for the week ending December 18, 2021. [WATCH TIME: 3 minutes]

Perampanel Improves Comorbid Intellectual Disability, Effects of CBTip in PNES, Cenobamate's Impact in Surgically-Refractory Patients

December 11, 2021

Neurology News Network for the week ending December 11, 2021. [WATCH TIME: 4 minutes]

Perampanel Improves Comorbid Epilepsy and Migraine, Masupidine to Treat Alzheimer Agitation, Fenfluramine Potential FDA-Approval in LGS

December 04, 2021

Neurology News Network for the week ending December 4, 2021. [WATCH TIME: 4 minutes]

ATH-1017 Phase 2 Completes Enrollment, Heart Rate Variability as SUDEP Biomarker, Migraine Not Associated With Insomnia

November 27, 2021

Neurology News Network for the week ending November 27, 2021.

AMX0035 Shows Safety in Alzheimer Disease, Outcomes of Urgent Prevention in TIA, FDA Grants IDE to NeuroPace's RNS System

November 20, 2021

Neurology News Network for the week ending November 20, 2021.